Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 130

Results For "Indian"

1398 News Found

Medtech player Healthium acquires CareNow
Packaging | September 02, 2021

Medtech player Healthium acquires CareNow

This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK


Morpen Laboratories to transfer its medical devices business to a wholly owned subsidiary
News | September 02, 2021

Morpen Laboratories to transfer its medical devices business to a wholly owned subsidiary

The revenues and profits derived from the new subsidiary will be consolidated in the parent company


Pharma tops India’s exports from SEZs
News | September 01, 2021

Pharma tops India’s exports from SEZs

As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational


Acute therapies drive overall pharma growth in July: Ind-Ra
News | August 30, 2021

Acute therapies drive overall pharma growth in July: Ind-Ra

The segment delivered strong sales growth of 20% YoY


South Asia’s first advanced Genomics Research Centre open in Hyderabad
Biotech | August 28, 2021

South Asia’s first advanced Genomics Research Centre open in Hyderabad

The centre established by Nucleome Informatics will take up the sequencing of 5,000 Covid genomes and 500 human genomes in the coming months


Covid-19 infected individuals need only one dose of Covaxin: ICMR study
News | August 28, 2021

Covid-19 infected individuals need only one dose of Covaxin: ICMR study

Blood samples were collected from 114 healthcare workers who received Covaxin in Chennai from February to May 2021


SEC recommends Phase I clinical trials for Reliance’s Covid-19 vaccine candidate
News | August 27, 2021

SEC recommends Phase I clinical trials for Reliance’s Covid-19 vaccine candidate

The company has to approach the DCGI for approval to commence the trials


Pharma continues to attract PE investments: Care Ratings
News | August 27, 2021

Pharma continues to attract PE investments: Care Ratings

In H1FY21, it attracted PE deals worth US $ 1.6 billion compared to US $ 3 billion in CY2020


Merck donates Rs 1.7 crore to IIT Bombay for Covid-19 research
News | August 26, 2021

Merck donates Rs 1.7 crore to IIT Bombay for Covid-19 research

The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology


RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant
Drug Approval | August 26, 2021

RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant

Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease